Latest Recombinant proteins Stories
PARIS, Feb. 25, 2015 /PRNewswire-USNewswire/ -- Sanofi announced today that the U.S.
DALLAS, February 20, 2015 /PRNewswire/ -- Global and Chinese Human Insulin Industry, 2009-2019 Market Research Report and Human Insulin Market by Product Type (Human Insulin
SAN DIEGO, Feb. 20, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc.
LONDON, Feb. 19, 2015 /PRNewswire/ -- In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million.
- Patients transitioned easily from multiple-daily insulin injections to PaQ®, which safely and effectively managed blood glucose - HORW, Switzerland, Feb.
--Total Funds Raised to Date Exceed $33 Million-- BRISBANE, Calif., Feb. 18, 2015 /PRNewswire/ -- Dance Biopharm Inc.
DEERFIELD, Ill., Feb. 11, 2015 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported that partner Baxter International Inc.
BRISBANE, Calif., Feb. 11, 2015 /PRNewswire/ -- Dance Biopharm Inc.
CSL Behring Achieves Another Key Milestone in PROLONG-9FP, its Recombinant Factor IX Fusion Protein Development Program; Continues to Advance CSL Behring's Legacy of Improving Patient Well-Being
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.